Harrow Health, Inc. (HROW)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$34.57
-5.40%
Mkt Cap $1.41B
Analyst Ratings
Buy
8
Hold
0
Sell
0
Price Target (14 analysts)
$73.67
Range $63.00 – $88.00
Implied Upside
+113.1%
Consensus $73.67 vs current $34.57